EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Incidence and Risk of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study

Jordan E Axelrad, Adam S Faye, Jonas Söderling, Karl Mårild, Jonas Halfvarson, Gábor Veress, Ola Olén, Jonas F Ludvigsson

Clinical Gastroenterology and Hepatology · 2026-09 · 24 (9) · 2524-2538

DOI: 10.1016/j.cgh.2026.01.043 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-09. Verfasst von Jordan E Axelrad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine, New York, New York. Electronic address: jordan.axelrad@nyulang…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colorectal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Individuals with inflammatory bowel disease (IBD) have an elevated risk of colorectal neoplasia (CRN), including colorectal dysplasia and cancer (CRC). Despite surveillance strategies to prevent CRC, the clinical course of dysplasia types remains poorly understood. METHODS: We conducted a nationwide cohort study using the Swedish Patient Register and the ESPRESSO histopathology cohort to identify patients diagnosed with IBD between 1969 and 2023. Patients were classified according to their first (baseline) incident episode of dysplasia (no dysplasia [ND]; indefinite [IND]; low-grade [LGD]; high-grade [HGD]). Our primary outcome was future advanced CRN (HGD or CRC) during follow-up. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) were estimated using Cox regression. RESULTS: We identified 54,534 patients with IBD, including 1320 with a first (baseline) episode of dysplasia (264 IND, 1031 LGD, 25 HGD), and 53,214 with ND. Over a median follow-up of 13.3 years, 2.3% of patients with ND had future advanced CRN compared with 5.3% of patients with IND (aHR, 1.85; 95% CI, 1.09-3.15) and 8.3% of patients with LGD (aHR, 3.51; 95% CI, 2.77-4.45). Of those with HGD, 40% developed CRC (aHR, 47.88; 95% CI, 25.53-89.80). Risk factors for future dysplasia included male sex, younger age at diagnosis, extensive colitis, primary sclerosing cholangitis, and histologic inflammation. CONCLUSIONS: Patients with IBD and dysplasia have a significantly increased risk of future dysplasia, particularly among patients with HGD. Personalized surveillance strategies based on risk factors are critical for preventing advanced CRN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesColorectal NeoplasmsHumansMaleFemaleSwedenIncidenceCohort StudiesAdultMiddle AgedYoung AdultAgedAdolescentRisk Factors

Stichwörter der Autor:innen

Colorectal CancerCrohn’s DiseaseDysplasiaNeoplasiaSurveillanceUlcerative Colitis

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine, New York, New York. Electronic address: jordan.axelrad@nyulangone.org.
  • Division of Gastroenterology, Department of Medicine, NYU Grossman School of Medicine, New York, New York.
  • Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden; Department of Pediatrics, Queen Silvia Children's Hospital, Gothenburg, Sweden.
  • Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Department of Laboratory Medicine, Faculty for Medicine and Health, Örebro University, Örebro University Hospital, Örebro, Sweden.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Axelrad, J. E., Faye, A. S., Söderling, J., Mårild, K., Halfvarson, J., Veress, G., Olén, O., & Ludvigsson, J. F. (2026). Incidence and Risk of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study. Clinical Gastroenterology and Hepatology, 24(9), 2524-2538. https://doi.org/10.1016/j.cgh.2026.01.043

Vancouver

Axelrad JE, Faye AS, Söderling J, Mårild K, Halfvarson J, Veress G, et al. Incidence and Risk of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study. Clinical Gastroenterology and Hepatology. 2026;24(9):2524-2538. doi:10.1016/j.cgh.2026.01.043

BibTeX
@article{Axelrad2026,
  author = {Axelrad, Jordan E and Faye, Adam S and Söderling, Jonas and Mårild, Karl and Halfvarson, Jonas and Veress, Gábor and Olén, Ola and Ludvigsson, Jonas F},
  title = {Incidence and Risk of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {9},
  pages = {2524--2538},
  doi = {10.1016/j.cgh.2026.01.043}
}
Kostenlos starten →